Position in MRK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,432,890
+$146,418 QoQ
Shares Held
18,933
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#1,465
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Van Cleef Asset Management,Inc holds $14,679,161 across 8 Drug Manufacturers - General names. MRK ranks #3 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,838 | $4,276,346 | |
| 2 | LLY |
ELI LILLY & Co
|
2,762 | $3,312,825 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
18,933 | $2,432,890 | |
| 4 | ABBV |
AbbVie Inc.
|
7,570 | $1,904,914 | |
| 5 | PFE |
Pfizer Inc
|
44,347 | $1,067,875 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,952 | $625,635 | |
| 7 | AMGN |
Amgen Inc
|
1,572 | $569,252 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,494 | $489,424 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,432,890 | 18,933 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,286,472 | 19,008 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,006,045 | 19,058 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,599,537 | 19,058 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,532,379 | 19,358 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,737,574 | 19,358 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,089,875 | 21,008 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,392,482 | 21,068 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,606,732 | 21,056 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,798,131 | 21,206 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,333,573 | 21,405 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $2,224,440 | 21,607 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $2,510,309 | 21,755 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,292,704 | 21,550 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,407,504 | 21,699 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,886,028 | 21,900 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,010,298 | 22,050 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,827,581 | 22,274 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,707,079 | 22,274 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,669,995 | 22,234 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,729,138 | 22,234 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,714,019 | 22,234 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,818,740 | 22,234 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $1,844,311 | 22,234 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,719,355 | 22,234 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $2,387,754 | 31,034 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||